Literature DB >> 16698886

AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?

Carme Borrell1, Maica Rodríguez-Sanz, M Isabel Pasarín, M Teresa Brugal, Patricia García-de-Olalla, Marc Marí-Dell'Olmo, Joan Caylà.   

Abstract

BACKGROUND: The aim of this study is to determine whether socioeconomic AIDS mortality inequalities before and after the introduction of highly active antiretroviral therapy (HAART) have increased or decreased in a Spanish city where HAART is free.
METHODS: The study used a trend design, including all Barcelona residents older than 19 years of age. All AIDS deaths, which occurred among these residents between 1991 and 2001 were included. The variables studied were age, sex, socioeconomic (SES) group and HIV transmission group. AIDS age-standardized mortality rates for each year were estimated. Poisson regression models were fitted to obtain the relative risk (RR) of AIDS death for each socioeconomic group with respect to the reference group.
RESULTS: AIDS mortality increased up until 1995 and subsequently decreased due to the introduction of HAART. The increase in AIDS mortality was greater in the lowest SES group, which had higher rates and a RR of dying larger than that of the highest SES group, fact that remained fairly stable over the whole period. A similar pattern was observed in intravenous drug users. In the homosexual transmission group, rates for the lowest SES group were higher for the whole period and increased until 1996, while rates for the other SES groups were lower and decreased over the entire period.
CONCLUSIONS: The fact that inequalities in AIDS mortality by SES group remained fairly stable for the whole period suggests that perhaps access to HAART, or adherence, is lower than desirable, in people of lower SES groups. These results ought to be taken into account when implementing treatment and prevention strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16698886     DOI: 10.1093/eurpub/ckl062

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  19 in total

1.  Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy.

Authors:  Benjamin Chin-Yee; S V Subramanian; Amol A Verma; Andreas Laupacis; Fahad Razak
Journal:  Milbank Q       Date:  2018-06       Impact factor: 4.911

2.  Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe.

Authors:  Marc Marí-Dell'Olmo; Maica Rodríguez-Sanz; Patrícia Garcia-Olalla; M Isabel Pasarín; M Teresa Brugal; Joan A Caylà; Carme Borrell
Journal:  J Epidemiol Community Health       Date:  2007-03       Impact factor: 3.710

3.  Gender differences in health related quality of life of young heroin users.

Authors:  Antònia Domingo-Salvany; M Teresa Brugal; Gregorio Barrio; Francisco González-Saiz; M José Bravo; Luís de la Fuente
Journal:  Health Qual Life Outcomes       Date:  2010-12-01       Impact factor: 3.186

4.  Role of Education in HIV Clinical Outcomes in a Tuberculosis Endemic Setting.

Authors:  Gabriel M Cohen; Lise Werner; Santhanalakshmi Gengiah; Kogieleum Naidoo
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-24

5.  The effects of HIV on P300 are moderated by familial risk for substance dependence: implications for a theory of brain reserve.

Authors:  Lance O Bauer
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

6.  Impact of selective evidence presentation on judgments of health inequality trends: an experimental study.

Authors:  Sam Harper; Nicholas B King; Meredith E Young
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

7.  Widening Socioeconomic, Racial, and Geographic Disparities in HIV/AIDS Mortality in the United States, 1987-2011.

Authors:  Gopal K Singh; Romuladus E Azuine; Mohammad Siahpush
Journal:  Adv Prev Med       Date:  2013-05-07

Review 8.  Use of relative and absolute effect measures in reporting health inequalities: structured review.

Authors:  Nicholas B King; Sam Harper; Meredith E Young
Journal:  BMJ       Date:  2012-09-03

9.  Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China.

Authors:  Jing Wang; Zhe Wang; Jia Liu; Yanchao Yue; Shimei Yang; Huimin Huang; Cui He; Lingjie Liao; Hui Xing; Yuhua Ruan; Yiming Shao
Journal:  Sci Rep       Date:  2015-10-08       Impact factor: 4.379

10.  Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China.

Authors:  Shujia Liang; Zhiyong Shen; Jing Yan; Fuxiong Liang; Zhenzhu Tang; Wei Liu; Wei Kan; Lingjie Liao; Xuebing Leng; Yuhua Ruan; Hui Xing; Yiming Shao
Journal:  Front Public Health       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.